Clinical trials: Acute Promyelocytic Leukemia With PML-RARA

Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia

A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)

• Not yet recruiting
• Age: 12 years and older
• Phase 3
• Pill or oral medicine
• Injection or infusion

LATITUDE: A Phase 3, Randomized, Open-Label, 3-Cohort, 2-Period, 2- Sequence, Crossover Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of Oral Arsenic Trioxide Versus Intravenous Arsenic Trioxide for Consolidation…

Conditions

Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA

Trial name

LATITUDE (NCT07296445)

Testing

Oral ATO, IV Arsenic Trioxide, all-trans retinoic acid (ATRA)

Volunteers

120 people

Sponsor

SDK Therapeutics, Inc.